Profusa, Inc. Common Stock (PFSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 1.76 |
| Open | 1.8 |
| Day High | 1.8 |
| Day Low | 1.6 |
| 52-Week High | 4,162.5 |
| 52-Week Low | 1.6 |
| Volume | 25,230 |
| Average Volume | 180,129 |
| Market Cap | 38,085 |
| PE | -0.02 |
| EPS | -99.88 |
| Moving Average 50 Days | 5.45 |
| Moving Average 200 Days | 144.36 |
| Change | -0.05 |
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
GlobeNewswire Inc.
Feb 27, 2026 2:15 PM GMT
After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to Achieve Near-term Revenue Projections BERKELEY, CA, F
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
GlobeNewswire Inc.
Feb 19, 2026 1:30 PM GMT
With strong underlying market demand, European distributor and expert physician customer purchase orders are being received by the Company as its 2026 revenue guidance range increases to $1.5 million - $3 million BERKELEY, Calif, Feb. 19, 2026 (GLO
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
GlobeNewswire Inc.
Feb 12, 2026 9:30 PM GMT
Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product Seeking to develop and commercialize new tethered continuous oxygen monitoring products for hi